Derek L Crookes is a notable inventor based in Ware, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments aimed at treating conditions associated with cephalic pain, such as migraines. With a total of 5 patents to his name, Crookes continues to push the boundaries of medical innovation.

Latest Patents

Among his latest patents, Crookes has developed a compound known as 3-2-(dimethylamino)ethyl!-N-methyl-1H-methanesulphonamide sulphate salt (2:1) and its pharmaceutically acceptable solvates. This compound is particularly useful in the treatment of migraines and is formulated for intranasal administration. Another significant patent involves the compound 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate salt (2:1), which is also aimed at creating effective intranasal formulations for migraine treatment.

Career Highlights

Derek L Crookes is associated with Glaxo Group Limited, a leading pharmaceutical company. His work focuses on developing innovative solutions that address pressing medical needs. His contributions have been instrumental in advancing the understanding and treatment of migraine-related conditions.

Collaborations

Throughout his career, Crookes has collaborated with talented individuals such as Joanne Craig and Stephen John Skittrall. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Derek L Crookes exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to improving treatments for migraine sufferers through his patented inventions highlights the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com